Skip to main content
. 2019 Dec 4;20(7):1236–1241. doi: 10.1093/annonc/mdn769

Figure 2.

Figure 2

Progression-free survival from the time of liver resection for the patients treated with adjuvant HAI FUDR/Dex plus systemic oxaliplatin/5-FU/LV. HAI, hepatic arterial infusion; FUDR, floxuridine; Dex, dexamethasone; 5-FU, 5-fluorouracil; LV, leucovorin.